We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$26B
AUM Growth
+$2.7B
Cap. Flow
-$57.1M
Cap. Flow %
-0.22%
Top 10 Hldgs %
42.98%
Holding
282
New
15
Increased
82
Reduced
90
Closed
11

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$21.2M
2
PGR icon
Progressive
PGR
+$20.5M
3
INTU icon
Intuit
INTU
+$20.4M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$18.3M
5
AMZN icon
Amazon
AMZN
+$10.4M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$36.6M
2
AAPL icon
Apple
AAPL
+$30.9M
3
CB icon
Chubb
CB
+$21.2M
4
ABBV icon
AbbVie
ABBV
+$11.6M
5
ASML icon
ASML
ASML
+$8.35M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Financials 19.28%
3 Consumer Staples 19.24%
4 Communication Services 10.61%
5 Healthcare 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
101
Eli Lilly
LLY
$995B
$5.38M 0.02%
31,857
-765
-2% -$114K
GILD icon
102
Gilead Sciences
GILD
$168B
$5.37M 0.02%
92,120
-4,287
-4% -$259K
GOOGL icon
103
Alphabet (Google) Class A
GOOGL
$4.62T
$5.05M 0.02%
57,620
+3,480
+6% +$293K
SPY icon
104
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$4.98M 0.02%
13,314
+9,122
+218% +$3.24M
FMX icon
105
Fomento Económico Mexicano
FMX
$43B
$4.87M 0.02%
64,210
-350
-0.5% -$23.4K
EOG icon
106
EOG Resources
EOG
$76.4B
$4.82M 0.02%
96,672
-508
-0.5% -$22.1K
COST icon
107
Costco
COST
$420B
$4.72M 0.02%
12,530
+67
+0.5% +$25K
CAT icon
108
Caterpillar
CAT
$404B
$4.47M 0.02%
24,562
+500
+2% +$84.8K
SBR
109
Sabine Royalty Trust
SBR
$1.05B
$4.27M 0.02%
151,249
SJM icon
110
J.M. Smucker
SJM
$12.7B
$4.23M 0.02%
36,624
LMT icon
111
Lockheed Martin
LMT
$136B
$4.19M 0.02%
11,815
+2,185
+23% +$803K
PAGP icon
112
Plains GP Holdings
PAGP
$5.04B
$4.17M 0.02%
494,052
CL icon
113
Colgate-Palmolive
CL
$73.8B
$4.03M 0.02%
47,121
+888
+2% +$73.4K
CDK
114
DELISTED
CDK Global, Inc.
CDK
$3.97M 0.02%
76,539
-919
-1% -$43.6K
FOXA icon
115
Fox Class A
FOXA
$24.8B
$3.92M 0.02%
134,572
-13,845
-9% -$387K
SLB icon
116
SLB Ltd
SLB
$75.4B
$3.88M 0.01%
124,794
LUV icon
117
Southwest Airlines
LUV
$23.8B
$3.78M 0.01%
81,057
-20,725
-20% -$898K
RETA
118
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.73M 0.01%
30,129
SCI icon
119
Service Corp International
SCI
$11.7B
$3.66M 0.01%
74,500
WFC icon
120
Wells Fargo
WFC
$267B
$3.65M 0.01%
121,094
-9,532
-7% -$247K
UL icon
121
Unilever
UL
$138B
$3.55M 0.01%
52,301
+47,811
+1,065% +$3.24M
LEG icon
122
Leggett & Platt
LEG
$1.43B
$3.54M 0.01%
80,000
NOVA
123
DELISTED
Sunnova Energy
NOVA
$3.46M 0.01%
76,771
NSC icon
124
Norfolk Southern
NSC
$76.7B
$3.11M 0.01%
13,071
-1,230
-9% -$280K
ORCL icon
125
Oracle
ORCL
$420B
$3.04M 0.01%
46,925
+9
+0% +$536

Similar funds

Fayez Sarofim & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Fayez Sarofim & Co held 282 positions worth $26B, up 12% from $23.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q4 2020 filing shows 15 new, 82 increased, 90 reduced and 11 closed positions. Its largest new stake was Viatris: 86,257 shares worth $1.62M. The largest sale was ExxonMobil, an estimated $36.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q4 2020 buy was Viatris: 86,257 shares worth $1.62M.
  • Fayez Sarofim & Co added most to Adobe in Q4 2020, an estimated $21.2M increase.
  • Fayez Sarofim & Co's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $36.6M.
  • Fayez Sarofim & Co fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $3.64M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $26B portfolio in Q4 2020.
  • Fayez Sarofim & Co opened 15 new positions and closed 11 in Q4 2020.
  • Fayez Sarofim & Co's portfolio value rose 12% quarter-over-quarter to $26B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2020, filed 11 Feb 2021.